Loading...
Loading...
Below are the top small-cap diagnostic substances stocks on the NYSE and the NASDAQ in terms of operating margin.
The trailing-twelve-month operating margin at SurModics
SRDX is 32.12%. SurModics had $28.43 million in total cash for the latest quarter.
The trailing-twelve-month operating margin at Meridian Bioscience
VIVO is 30.48%. Meridian Bioscience's ROE for the same period is 25.63%.
The trailing-twelve-month operating margin at Trinity Biotech plc
TRIB is 19.54%. Trinity Biotech's revenue for the same period is $86.08 million.
The trailing-twelve-month operating margin at Quidel
QDEL is 10.92%. Quidel's PEG ratio is 5.12.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
We simplify the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in